ARCHIVES

DCCP Payback System Saving $1 Million Year

This article is from The Cancer Letter archive.

Vol. 08 No. 47 | December 3, 1982

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

NCI-Approved Clinical Trials

August 31, 2001

Schwetz Replaces Koski As HHS Human Research Protections Director

February 7, 2003